Orthopaedic device commercialization is no longer a topic for a select audience. It is, perhaps, the most pressing issue facing the industry, second only to patient outcomes. Clinical data, reimbursement, testing, UDI, quality measures, inventory management, price pressures; these topics only scratch the surface of “commercialization.” BONEZONE contributes to these important subjects by giving its readers a trustworthy and purposeful perspective. Actionable advice, practical tools and guidance from real people who have first-hand knowledge of the trials and errors it takes to fuel progress are the foundation of BONEZONE’s editorial content.
Bolstered by two decades of providing strategic insights to industry CEOs, BONEZONE’s leadership is uniquely equipped to tackle complex issues, translating them into articles that readers can absorb to boost their competence and ultimately, their contributions to their companies.
“Voice of customer” is the driving force behind all of ORTHOWORLD’s offerings, and BONEZONE leverages surveys and input from its Advisory Board to keep content relevant and useful to readers. Executives from the following companies presently suggest and critique content: Active Implants | Arthrex | DePuy Synthes | Medtronic | MicroPort Orthopedics Smith & Nephew | Stryker | Tyber Medical | Wright Medical | Zimmer Biomet